Cargando…

Advances in highly active one-carbon metabolism in cancer diagnosis, treatment and drug resistance: A systematic review

STUDY BACKGROUND OBJECTIVES: Cancer poses a significant health concern as it is incurable. Every year, research on how to treat and eradicate this chronic condition is done. This systematic review will unmask the recent developments concerning highly active 1C metabolism with regard to cancer diagno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shuang, Wang, Zheng-Miao, Lv, Dong-Mei, Zhao, Yi-Xuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751587/ https://www.ncbi.nlm.nih.gov/pubmed/36531038 http://dx.doi.org/10.3389/fonc.2022.1063305

Ejemplares similares

Editorial: The role of one-carbon metabolism in cancer progression, therapy, and resistance
por: Thakur, Abhimanyu, et al.
Publicado: (2023)

Relationship between metabolic reprogramming and drug resistance in breast cancer
por: Lv, Linlin, et al.
Publicado: (2022)

Serine-associated one-carbon metabolic reprogramming: a new anti-cancer therapeutic strategy
por: Zhang, Jing, et al.
Publicado: (2023)

Advances in Renal Cell Carcinoma Drug Resistance Models
por: Xiang, Yien, et al.
Publicado: (2022)

Trends in metabolic signaling pathways of tumor drug resistance: A scientometric analysis
por: Jiang, Ruiqi, et al.
Publicado: (2022)

The Role of Sphingolipids Metabolism in Cancer Drug Resistance
por: Bataller, Marina, et al.
Publicado: (2021)

Advances in the Study of CircRNAs in Tumor Drug Resistance
por: Wang, Song, et al.
Publicado: (2022)

Association of One-Carbon Metabolism-Related Vitamins (Folate, B6, B12), Homocysteine and Methionine With the Risk of Lung Cancer: Systematic Review and Meta-Analysis
por: Yang, Jia, et al.
Publicado: (2018)

Editorial: Recent advances of drug resistance research in colorectal cancer therapy
por: Ye, Chenyang, et al.
Publicado: (2022)

Metabolic changes underlying drug resistance in the multiple myeloma tumor microenvironment
por: Matamala Montoya, María, et al.
Publicado: (2023)

The Efficacy and Safety of Carbon Ion Radiotherapy for Meningiomas: A Systematic Review and Meta-Analysis
por: Li, Jie-yun, et al.
Publicado: (2021)

Chemotherapy Reverses Anti-PD-1 Resistance in One Patient With Advanced Non-small Lung Cell Cancer
por: Zhao, Lingdi, et al.
Publicado: (2020)

STAT3-Mediated Metabolic Reprograming in Cellular Transformation and Implications for Drug Resistance
por: Poli, Valeria, et al.
Publicado: (2015)

Possible mechanism of metabolic and drug resistance with L-asparaginase therapy in childhood leukaemia
por: Zhou, Ruizhi, et al.
Publicado: (2023)

Recent advances of pathomics in colorectal cancer diagnosis and prognosis
por: Wu, Yihan, et al.
Publicado: (2023)

Overexpression of ABCC1 Confers Drug Resistance to Betulin
por: Chen, Xuan-Yu, et al.
Publicado: (2021)

Anti-Angiogenic Drugs Inhibit Interstitial Lung Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer
por: Wang, Yanning, et al.
Publicado: (2022)

Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Drug-Resistant Gastrointestinal Stromal Tumors: A Feasibility Study
por: Li, Longhao, et al.
Publicado: (2020)

The Latest Overview of circRNA in the Progression, Diagnosis, Prognosis, Treatment, and Drug Resistance of Hepatocellular Carcinoma
por: Xiong, Dandan, et al.
Publicado: (2021)

Sentinel Lymph Node Biopsy Mapped With Carbon Nanoparticle Suspensions in Patients With Breast Cancer: A Systematic Review and Meta-Analysis
por: Jiang, Yan, et al.
Publicado: (2022)

Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies
por: Wang, Lishun, et al.
Publicado: (2023)

Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analysis
por: Yi, Xiao-Fang, et al.
Publicado: (2022)

Role of tumor-derived exosomes in metastasis, drug resistance and diagnosis of clear cell renal cell carcinoma
por: Jiang, Tiancheng, et al.
Publicado: (2022)

Rational Targeting of Cdc42 Overcomes Drug Resistance of Multiple Myeloma
por: Nguyen, Phuong, et al.
Publicado: (2019)

Ataxia-Telangiectasia Mutated Modulation of Carbon Metabolism in Cancer
por: Dahl, Erika S., et al.
Publicado: (2017)

Metabolic reprogramming of three major nutrients in platinum-resistant ovarian cancer
por: Yan, Jinbowen, et al.
Publicado: (2023)

Research Progress of Antibody–Drug Conjugate Therapy for Advanced Gastric Cancer
por: Wang, Na, et al.
Publicado: (2022)

Recent advances microRNAs and metabolic reprogramming in colorectal cancer research
por: Xiong, Bin, et al.
Publicado: (2023)

Effectiveness of Carbon Ion Radiation in Locally Advanced Pancreatic Cancer
por: Liermann, Jakob, et al.
Publicado: (2021)

The Non-Coding RNAs Inducing Drug Resistance in Ovarian Cancer: A New Perspective for Understanding Drug Resistance
por: Li, Gaofeng, et al.
Publicado: (2021)

The Advance of Magnetic Resonance Elastography in Tumor Diagnosis
por: Yang, Jin-Ying, et al.
Publicado: (2021)

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma
por: Palmieri, Giuseppe, et al.
Publicado: (2021)

Quantitative Proteomic Profiling Identifies SOX8 as Novel Regulator of Drug Resistance in Gestational Trophoblastic Neoplasia
por: Jun, Fu, et al.
Publicado: (2020)

The Changing Role of Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Updated Systemic Review and Network Meta-Analysis
por: Liu, Mei, et al.
Publicado: (2018)

Publication trends and hotspots of drug resistance in colorectal cancer during 2002-2021: A bibliometric and visualized analysis
por: Zhao, Peng-yue, et al.
Publicado: (2022)

Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer
por: Hu, Xianwen, et al.
Publicado: (2022)

Glucose Metabolism on Tumor Plasticity, Diagnosis, and Treatment
por: Lin, Xiaoping, et al.
Publicado: (2020)

Research Advances on Anti-Cancer Natural Products
por: Guo, Meng, et al.
Publicado: (2022)

Editorial: Molecular Advances in Diagnosis and Treatment of CNS Tumors
por: Zhang, Zhao-Hui, et al.
Publicado: (2020)

Editorial: Recent Advances in Diagnosis and Management of Urothelial Carcinoma
por: Ku, Ja Hyeon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ead6fldpnp7pdpc0pjtk4bg08r